Marc Duey insider trades
Open-market stock purchases and sales by Marc Duey, Director at Aprea Therapeutics, Inc, from SEC Form 4 filings since Jul 28, 2022.
Track record: 0% of 3 scored buys are up 5% or more since purchase, averaging -72%.
Companies traded
- APRE Aprea Therapeutics, Inc: 3 buys, 1 sale, last Jun 16, 2026